Vaxart, Inc. (VXRT)

Trade VXRT now with
11/9/2018 8:49:48 AM Vaxart Q3 Net Loss $6.5 Mln Vs Net Loss $2.2 Mln Last Year
6/4/2018 7:06:15 AM Vaxart Reports Phase 2 Trial Of Teslexivir Does Not Meet Primary Efficacy Endpoint
5/1/2018 8:04:12 AM Vaxart Appoints David Taylor As Chief Medical Officer
1/11/2018 7:55:02 PM Aviragen Board Recommends Tht Stockholders Vote FOR Proposed Merger With Vaxart
12/22/2015 8:35:31 AM FBR Capital Markets Starts Biota Pharmaceuticals Inc. (BOTA) At Outperform With $6 Price Target